Biography
Rushad Pavri is a Senior Lecturer in the Peter Gorer Department of Immunobiology. His research program focuses on the molecular mechanisms of antibody maturation and the genome instability in B cells. He did his PhD from The University of Medicine and Dentistry of New Jersey, USA (advisor: Danny Reinberg) and his postdoctoral research at The Rockefeller University, New York, USA (advisor: Michel Nussenzweig). From 2013-2023, he was an independent Research Group Leader at the Research Institute of Molecular Pathology (IMP) in Vienna, Austria.
PURE Profile: https://kclpure.kcl.ac.uk/portal/en/persons/rushad.pavri
Research
Pavri Group
The Pavri Group investigates the molecular mechanisms of somatic hypermutation (SHM), whereby B lymphocytes diversify the immunoglobulin genes to produce high-affinity antibodies of varying isotypes against pathogen and vaccine antigens.
Statistical and Computational Genetics and Genomics (SCGG) RIG
The SCGG Group brings together researchers at King’s who are developing and working with innovative quantitative and computational approaches for genomic discovery and its impact on human health.
Events
How chromatin architecture, transcription and replication regulate antibody maturation and oncogenic translocations in B cells
Seminar with Dr Rushad Pavri
Please note: this event has passed.
Research
Pavri Group
The Pavri Group investigates the molecular mechanisms of somatic hypermutation (SHM), whereby B lymphocytes diversify the immunoglobulin genes to produce high-affinity antibodies of varying isotypes against pathogen and vaccine antigens.
Statistical and Computational Genetics and Genomics (SCGG) RIG
The SCGG Group brings together researchers at King’s who are developing and working with innovative quantitative and computational approaches for genomic discovery and its impact on human health.
Events
How chromatin architecture, transcription and replication regulate antibody maturation and oncogenic translocations in B cells
Seminar with Dr Rushad Pavri
Please note: this event has passed.